FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes

 

Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Lantus SoloStar(R), a new prefilled disposable insulin pen for once-daily 24- hour insulin LANTUS(R) (insulin glargine) for the treatment of hyperglycemia in people with type 1 or type 2 diabetes.
The introduction of Lantus SoloStar(R) offers a convenient option for administering once-daily 24-hour LANTUS(R), the number one prescribed insulin in the world. LANTUS(R) in the Lantus SoloStar(R) pen provides diabetes patients with an alternative to the traditional needle and syringe for insulin therapy. Lantus SoloStar(R) is the only disposable insulin pen that allows patients to administer doses from 1 up to 80 units, in one injection.

Source: FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes

No comments:

Post a Comment